This site is intended for healthcare professionals only
LoginRegister
Novartis concludes acquisition of Regulus TherapeuticsSanofi to acquire Blueprint Medicines for up to USD 9.5 billion
CDSCO Panel Approves GSKs Proposal to Double Indian Patient Pool in Dostarlimab TrialGSK Linerixibat application for cholestatic pruritus in primary biliary cholangitis patients under...
GSK Pharma: Chinmay Sharma appointed HRBL, Performance Emerging Markets based out of London; Harsh V Trehan named India HR HeadGSK Pharma: Chinmay Sharma appointed HRBL, Performance Emerging Markets based out of London; Harsh V...
Biocon, NCSM partnerCDSCO approves Biocon diabetes drug Liraglutide
DMC Registrar Resigns After Govt Threatens Dissolution of CouncilGranules India Krishnamohan B resigns as Vice President & Head- IT
Alembic Pharma gets four USFDA observations for Panelav facilityAlembic Pharma gets four USFDA observations for Panelav facility
Cipla appoints Prabhakaran Balakrishnan Nair as Global Chief Manufacturing OfficerCipla appoints Prabhakaran Balakrishnan Nair as Global Chief Manufacturing Officer
CDSCO Panel Approves BE Study for Alkems Dapagliflozin, Pioglitazone, Metformin FDC, Seeks Revised Phase III PlanCDSCO Panel Approves BE Study for Alkem's Dapagliflozin, Pioglitazone, Metformin FDC, Seeks Revised...
AbbVie seeks USFDA nod for combination regimen of Venclexta, AcalabrutinibZydus Lifesciences Rifaximin Tablets bags USFDA tentative nod for irritable bowel syndrome with...
Dr Reddys Labs gets USFDA EIR for Miryalaguda facilityDr Reddy's Gets Rs 2,395 Crore Tax Notice Over Merger, Says No Material Impact
Shilpa Medicare Dabaspet unit gets VAI classification from USFDAUSFDA successfully completes inspection at Piramal Pharma Canada facility
Cipla inks pacts to invest in iCaltech InnovationsCipla (EU), UK incorporates new wholly owned subsidiary in Germany
X